Quinolone resistance and campylobacter spp

Journal of Antimicrobial Chemotherapy

Volumn 36, Issue 6, 1995, Pages 891-898

  Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ERYTHROMYCIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TETRACYCLINE; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

AGRICULTURE; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; CAMPYLOBACTER; CROSS RESISTANCE; DIARRHEA; DRUG USE; FOOD CHAIN; GENE MUTATION; GRAM NEGATIVE INFECTION; HUMAN; NONHUMAN; POULTRY; REVIEW; STRAIN DIFFERENCE; TRAVEL; TREATMENT FAILURE; UNITED KINGDOM; ANIMAL; DRUG EFFECT;

ANIMALS; ANTI-INFECTIVE AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HUMANS;

EID: 0029433557     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/36.6.891     Document Type: Review

References (41)

1. Adler-Mosca, H., Luthy-Hottenstein, J., Martinetti Luchini, G., Bumens, A. and Altwegg, M. (1991). Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. European Journal of Clinical Microbiology and Infectious Diseases 10, 953-7.
2. Altwegg, M., Burnens, A., Zollinger-Iten, J. and Penner, J. L. (1987). Problems of identification of Campylobacter jejuni associated with resistance to nalidixic acid. Journal of Clinical Microbiology 25, 1807-8.
3. Bakhtiar, M. and Shanson, D. C. (1991). Observations of ciprofloxacin resistance in gut pathogens from patients with AIDS. In Proceedings of the Seventeenth International Congress of Chemotherapy, Berlin, 1991. Abstract 1548.
4. Bernard, E., Roger, P. M., Carles, D., Bonaldi, V., Fournier, J. P. and Dellamonica, P. (1989). Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus. Journal of Infectious Diseases 159, 143-4.
5. Bowler, I. and Day, D. (1992) Emerging quinolone resistance in Campylobacters. Lancet 340, 245.
6. de Mol, P. (1994). Human campylobacteriosis: clinical and epidemiological aspects. Dairy, Food and Environmental Sanitation 14, 314-6.
7. DuPont, H. L. (1991). Use of quinolones in the treatment of gastrointestinal infections. European Journal of Clinical Microbiology and Infectious Diseases 10, 325-9.
8. DuPont, H. L. and Steel, J. H. (1987). Use of antimicrobial agents in animal feeds: implications for human health. Reviews in Infectious Diseases 9, 447-60.
9. Endtz, H. P., Broeron, M. and Mouton, R. P. (1993). In vitro susceptibility of quinolone-resistant Campylobacter jejuni to new macrolide antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 12, 48-50.
10. Endtz, H. P., Mouton, R. P., van der Reyden, T., Ruijs, G. J., Biever, M., and van Klingeren, B. Fluoroquinolone resistance in Campylobacter spp. isolated from human stools and poultry products Lancet 335, 787.
11. Endtz, H. P., Ruijs, G. J., van Klingeren, B., Jansen, W. H., van der Reyden, T. and Mouton, R. P. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. Journal of Antimicrobial Chemotherapy 27, 199-208.
12. Ericsson, C. D., Johnson, P. C. Dupont, H. L., Morgan, D. R., Bitsura, J. A. M. and de la Cabada, F. J. (1987). Ciprofloxacin or trimethoprim-sulphamethoxazole as initial therapy for travellers diarrhea. Annals of Internal Medicine 106, 216-20.
13. Evans, T. G. and Riley, D. (1992). Campylobacter lari colitis in a HIV-positive patient treated with a quinolone. Clinical Infectious Diseases 15, 172-3.
14. Fliegelman, R. M., Petrak, R. M., Goodman, L. J., Segreti, J., Trenholme, G. M. and Kaplan, R. L. (1985). Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrobial Agents and Chemotherapy 27, 429-30.
15. Gomez-Garces, J. L., Cogollos, R. and Alos, J. I. (1995). Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents. Antimicrobial Agents and Chemotherapy 39, 542-4.
16. Goodman, L. J., Trenholme, G. M., Kaplan, R. L., Segreti, J., Hines, D., Petrak, R. et al. (1990). Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Archives of Internal Medicine 150, 541-6.
17. Holmes, B., Brogden, R. N. and Richards, D. M. (1985). Norfloxacin: a review of antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 30, 482-513.
18. Jacobs-Reitsma, W. F., Kan, C. A. and Bolder, N. M. (1994). The induction of quinolone resistance in Campylobacter in broilders by quinolone treatment. Letters in Applied Microbiology 19, 228-31.
19. Jimenez, A., Velazquez, J. B., Rodriguez, J., Toinajas, A. and Villa, T. G. (1994). Prevalence of fluoroquinolone-resistance in clinical strains of Campylobacter jejuni isolated in Spain. Journal of Antimicrobial Chemotherapy 33, 188-90.
20. Lariviere, L. A., Gandreau, C. L. and Turgeon, F. F. (1986). Susceptibilities of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. Journal of Antimicrobial Chemotherapy 18, 681-5.
21. Maxwell, A. (1992). The molecular basis of quinolone action. Journal of Antimicrobial Chemotherapy 30, 409-14.
22. McIntyre, M. and Lyons, M. (1993). Resistance to ciprofloxacin in Campylobacter spp. Lancet 341, 188.
23. Nachamkin, I. (1993). Campylobacter infections. Current Opinion in Infectious Diseases 6, 72-6.
24. Pascual, A., Martinez-Martinez, L., Garcia-Gestoso, M. L. and Romero, J. (1994). Urinary tract infection caused by quinolone-resistant Campylobacter coli. European Journal of Clinical Microbiology and Infectious Diseases 13, 690-1.
25. Petrucelli, B. P., Murphy, G. S., Sanchez, J. L., Walz, S., DeFraites, R., Gelnett, J. et al. (1992). Treatment of traveler’s diarrhea with ciprofloxacin and loperamide. Journal of Infectious Diseases 165, 557-60.
26. Piddock, L. J. V. (1995). Mechanisms of resistance to fluoroquinolones: state of the art 1992-1994. Drugs, in press.
27. Rautelin, H., Renkonen, O. V. and Kosunen, T. U. (1993). Azithromycin resistance in Campylobacter jejuni and Campylobacter coli. European Journal of Clinical Microbiology and Infectious Diseases 12, 864-5.
28. Reina, J. and Alomar, P. (1990). Fluoroquinolone-resistance in thermophilic Campylobacter spp. isolated from stools of Spanish patients. Lancet 336, 186.
29. Reina, J., Borrell, N. and Serra, A. (1992). Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991. European Journal of Clinical Microbiology and Infectious Diseases 11, 1163-6.
30. Reina, J., Ros, M. J. and Femandez-Baca, V. (1995). Resistance to erythromycin in fluoroquinolone-resistant Campylobacter jejuni strains isolated from human faeces. Journal of Antimicrobial Chemotherapy 35, 351-2.
31. Sacks, L. J., Labriola, A. M., Gill, V. J. and Gordon, F. M. (1991). Use of ciprofloxacin for successful eradication of bacteremia due to Campylobacter cinaedi in human immunodeficiency virus infected person. Reviews in Infectious Diseases 13, 1066-8.
32. Sanchez, R., Femadez-Baca, V., Diaz, M. D., Munoz, P., Rodriguez-Criexems, M. and Bouza, E. (1994). Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrobial Agents and Chemotherapy 38, 1879-82.
33. Segreti, J., Gootz, T. D., Goodman, L. J., Parkhurst, G. W., Quinn, J. P., Martin, B. A. et al. (1992). High-level quinolone resistance in clinical isolates of Campylobacter jejuni. Journal of Infectious Diseases 165, 667-70.
34. Tauxe, R. J. (1992). Epidemiology of Campylobacter jejuni infections in the United States and other industrialised nations. In Campylobacter jejuni: Current status and Future Trends. (Nachamkin, I., Blase, M. J. and Tompkins, L. S., Eds), pp. 9-19. American Society for Microbiology, Washington, DC.
35. T aylor, D. E. and Courvalin, P. (1988). Mechanisms of antibiotic resistance in Campylobacter species. Antimicrobial Agents and Chemotherapy 32, 1107-12.
36. Taylor, D. E., Ng, L.-K. and Lior, H. (1985). Susceptibility of Campylobacter species to nalidixic acid, enoxacin and other DNA-gyrase inhibitors. Antimicrobial Agents and Chemotherapy 28, 708-10.
37. Taylor, D. N., Blaser, M. J., Escheverria, P., Pitarangsi, C., Bodhidatta, L. and Wang, W.-L. L. (1987). Erythromycin-reistant Campylobacter infections in Thailand. Antimicrobial Agents and Chemotherapy 31, 438-42.
38. Taylor, D. N., Sanchez, J. L., Candler, W., Thornton, S., McQueen, C. and Escheverria, P. (1991). Treatment of travellers diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. Annals of Internal Medicine 114, 731-4.
39. Velazquez, J. B., Jimenez, A., Chomon, B. and Villa, T. G. (1995). Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 35, 173-8.
40. Wang, Y., Huang, W. M. and Taylor, D. E. (1993). Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterisation of quinolone resistance mutations. Antimicrobial Agents and Chemotherapy 37, 457-63.
41. Wretlind, B., Strömberg, A., Ostlund, L., Sjögren, E. and Kaijser, B., (1992). Rapid emergence of quinolone-resistance in Campylobacter jejuni in patients treated with norfloxacin. Scandinavian Journal of Infectious Diseases 24, 685-6.